P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel

Autor: Brandao, M., Prisciandaro, E., Xenophontos, E., Mariolo, A., Sadeghi, A.H., Filippi, A.R., Levy, A., Bandura, A., Caramella, C., Dickhoff, C., de Margerie-Mellon, C., Faivre-Finn, C., Portik, D., Sanchez-Lorente, D., De Ruysscher, D., Smit, E., Gobbini, E., Fadel, E., Ruffini, E., Olmetto, E., Cortiula, F., Bahce, I., Houda, I., Opitz, I., Naidoo, J., Edwards, J., Remon, J., Benitez, J.C., Trujillo, J.C., Derks, J., Amrane, K., Hartemink, K., Stathopoulos, K., Hendriks, L., Iglesias, M., Occhipinti, M., Guckenberger, M., Giaj Levra, N., Girard, N., Reguart, N., Mercier, O., Bironzo, P., Hofman, P., Horsleben Petersen, R., De Angelis, R., Abgral, R., Terrisse, S., Popat, S., Pierret, T., Gerriet Blum, T., Ricardi, U., Dionisi, V., Berghmans, T., Dingemans, A.-M.

Publikováno v: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S292-S293